NHIQ — Nanthealth Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.33m
- $318.72m
- $67.00m
Brief: NantHealth Reports Q1 Revenue $22.3 Mln
Brief: Nanthealth Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing
Brief: Nanthealth Reports Q4 Loss Per Share $0.20
Brief: NantHealth reports 2017 third quarter financial results
BlackBerry's patent strategy head exits, joins health tech firm -sources
Brief: NantHealth reports Q2 loss per share $0.58
Brief: NantHealth - co entered asset purchase agreement with Allscripts Healthcare
Brief: Nanthealth says GPS cancer is now covered by Sistemas Medicos Nacionales
Brief: Nanthealth Inc - Blue Cross and Blue Shield of Nebraska has signed a three-year contract extension for NaviNet Open
Brief: Nanthealth Q1 adjusted non-gaap loss per share $0.24
Brief: Nanthealth appoints Dr. Sandeep Reddy as CMO
Brief: Nanthealth posts Q4 adj. loss per share $0.18
Brief: NantHealth announces pricing of $100 mln of 5.50 pct convertible notes
Brief: NantHealth announces proposed $100 million convertible notes offering
Brief: NantHealth, NantKwest and NantOmics announce availability of GPS cancer and phase i - iii quilt trials through the U.S. National Institutes of Health's ClinicalTrials.gov
Brief: Nanthealth announces exclusive agreement with Oncotest-Teva
Brief: NantHealth enters into reseller agreement with Lunatus
Brief: NantHealth reports Q3 loss per share $0.30
Brief: Nanthealth reports strong 2016 Q2 revenues and continued progress on GPS Cancer and nantos platform